2005
DOI: 10.1016/s1569-9056(05)80653-0
|View full text |Cite
|
Sign up to set email alerts
|

649Neurogenic bladder treatment by doubling the permissible anticholinergic dosage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2006
2006

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…This may be the result of either poor efficacy or unacceptable side effects of the drugs, mainly intense dry mouth. Before classifying a patient as having refractory NDO, one must recall that very often neurogenic patients tend to tolerate anticholinergics or much higher doses than those recommended by manufacturers without significant side effects (1–3). Moreover, if an anticholinergic becomes ineffective, the addition of a second one can still improve symptoms in the patients with severe NDO (4).…”
Section: Introductionmentioning
confidence: 99%
“…This may be the result of either poor efficacy or unacceptable side effects of the drugs, mainly intense dry mouth. Before classifying a patient as having refractory NDO, one must recall that very often neurogenic patients tend to tolerate anticholinergics or much higher doses than those recommended by manufacturers without significant side effects (1–3). Moreover, if an anticholinergic becomes ineffective, the addition of a second one can still improve symptoms in the patients with severe NDO (4).…”
Section: Introductionmentioning
confidence: 99%